Three changes manufacturers should consider in the wake of COVID-19.
Katie Rapp
Advertisement
Articles by Katie Rapp
Advertisement
Latest Updated Articles
How Cell and Gene Therapy Companies Can Adapt in an Evolving Commercial LandscapePublished: February 18th 2021 | Updated:
Pharmaceutical Distribution Trends to Watch in 2020Published: January 6th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Blenrep for Treatment of Replapsed/Refractory Multiple Myeloma
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
4
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
5
